Back to search

Article

Impaired SOX17 Expression Causes Endothelial Dysfunction and Pulmonary Arterial Hypertension by Insufficient Suppression of RUNX1

2026-05-15

Abstract excerpt

<h4>ABSTRACT</h4> Genome-wide association studies have identified rare and common mutations associated with increased risk of pulmonary arterial hypertension (PAH), but the mechanism by which impaired SOX17 expression increases PAH risk is not known. Notably, SOX17 plays a critical role in endothelial identity during development by suppressing RUNX1 through binding to its promoter and directing stem and progenito...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8056e827-4d84-5a1a-b53d-bf5343352de8
DOI
10.64898/2026.05.14.725187
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impaired SOX17 Expression Causes Endothelial Dysfunction and Pulmonary Arterial Hypertension by Insufficient Suppression of RUNX1DOI 10.64898/2026.05.14.725187
Select a neighboring publication to make it the new centre.